Hala M. H. Abaza

halaabaza@med.asu.edu.eg

Internal ID: rp10833
  • 20 Scopus Citations
  • 5 PubMed Citations

Loading... 2 0 20 0 false
 
Full Name
Hala M. H. Abaza
 
Personal Site
 
 
 
Scopus Author ID
 
WOS ID
 

Refined By:
Author:  Abaza H.M,H
Date Issued:  [2010 TO 2018]

Results 1-7 of 7 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
12010Expression of chemokine receptor “CXCR4” as a prognostic factor in acute Myeloid leukemia.Hala Abaza ; Ahmed A N ; El-Lebady D H ; Ismail L AA ; Osman L A A 
2Jan-2010Quantification of BCR/ABL fusion transcripts in chronic myeloid leukemia: follow up of therapeutic regimens and detection of minimal residual disease by real time polymerase chain reaction.Hala Abaza ; Mostafa G M H ; Negm Z M G ; Khattab D A ; Foad D A ; El-Arab S E 
31-Jan-2013Growth differentiation factor 15 expression in anemia of chronic disease and iron deficiency anemiaHala Abaza ; Rana E.A. El-Nashar ; Deena M.M. Habashy 
44-Apr-2015Detection of 14q32 rearrangements in multiple myeloma, using simultaneous FISH analysis combined with immunofluorescenceHala Abaza ; M.G.A. Ibrahim ; R.I. Annaka, L.M.H ; G.M. Hegazy ; A.A. Kamal ; S.R. Saad 
51-Jan-2016Platelet-dependent von Willebrand factor activity in acute myeloid leukemia patients: role in hemostatic alterationsAbaza H.M,H ; SF Samaan ; BAT Farweez 
61-Feb-2016Stanniocalcin1 gene expression in patients with acute leukemia: impact on response to therapy and disease outcomeHala Abaza ; H. M. Mahmoud ; H. M. A. El Maraghy ; M. I. Elmougy 
71-Apr-2018Neuropilin-1/CD304 expression by flow cytometry in Pediatric precursor B-acute lymphoblastic leukemia: A Minimal Residual Disease and Potential Prognostic Marker.Hala Abaza ; Abdel Fattah Mona F ; A nnaka Laila M ; Ebeid Fatma S ; Eissa Deena SN ; Alfeky Mervat AA